Stock Events

Stock Events

Cannara Biotech 

€1.05
45
-€0.01-0.94% Today

Statistics

Day High
1.06
Day Low
1.04
52W High
1.22
52W Low
0.71
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

14JulExpected
Q4 2025
Q1 2026
Next
0.01
0.01
0.02
0.03
Expected EPS
0.031082026000000002
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 8CB0.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Canopy Growth
CGC
Mkt Cap498.48M
Canopy Growth Corporation is a leading cannabis company in Canada, directly competing in the cannabis production and sales market with Cannara Biotech.
Aurora Cannabis
ACB
Mkt Cap201.62M
Aurora Cannabis is another major player in the cannabis industry, offering similar products such as cannabis strains, oils, and concentrates, directly competing with Cannara Biotech.
Tilray Brands
TLRY
Mkt Cap665M
Tilray is a global pioneer in cannabis research, cultivation, processing, and distribution, making it a direct competitor to Cannara Biotech in multiple markets.
Cronos Group
CRON
Mkt Cap955.73M
Cronos Group is involved in the production and sale of cannabis and cannabis-derived products, competing in the same space as Cannara Biotech.
Green Thumb Industries
GTBIF
Mkt Cap1.78B
Green Thumb Industries Inc. operates as a diversified cannabis company in the United States, competing with Cannara Biotech's expansion and product offerings.
Trulite
TRUL
Mkt Cap212,013
Trulieve Cannabis Corp. is a leading cannabis company in the U.S with a similar business model, competing in cultivation and retail, which overlaps with Cannara Biotech's market.
Direxion Daily CSI China Internet Index Bull 2X
CWEB
Mkt Cap0
Charlotte's Web Holdings, Inc. specializes in hemp-derived CBD products, competing in the wellness segment of the cannabis market where Cannara Biotech is also positioned.

About

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. It also offers hemp-based CBD products through e-commerce platform. The company was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.
Show more...
CEO
Mr. Zohar Krivorot
Employees
461
Country
Canada
ISIN
CA13765U2002

Listings

STU
DE
8CB0.STU
MU
DE
8CB0.MU
OTC Link
US
LOVFF
F
DE
8CB0.F

0 Comments

Share your thoughts

FAQ

What is Cannara Biotech stock price today?▼
The current price of 8CB0.STU is €1.05 EUR — it has decreased by -0.94% in the past 24 hours. Watch Cannara Biotech stock price performance more closely on the chart.
What is Cannara Biotech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Cannara Biotech stocks are traded under the ticker 8CB0.STU.
Is Cannara Biotech stock price growing?▼
8CB0.STU stock has fallen by -0.94% compared to the previous week, the month change is a -8.7% fall, over the last year Cannara Biotech has showed a +30.43% increase.
When is the next Cannara Biotech earnings date?▼
Cannara Biotech is going to release the next earnings report on July 14, 2026.
What were Cannara Biotech earnings last quarter?▼
8CB0.STU earnings for the last quarter are 0.01 EUR per share, whereas the estimation was 0.03 EUR resulting in a -60% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Cannara Biotech have?▼
As of May 11, 2026, the company has 461 employees.
In which sector is Cannara Biotech located?▼
Cannara Biotech operates in the Health & Wellness sector.
When did Cannara Biotech complete a stock split?▼
Cannara Biotech has not had any recent stock splits.
Where is Cannara Biotech headquartered?▼
Cannara Biotech is headquartered in Saint-Laurent, Canada.